SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
AGMB

AgomAb Therapeutics NV (NASDAQ:AGMB)

BE · Delayed Price · Currency is USD
Healthcare · Biotechnology
8.45-0.60 (-6.63%)
 
Market cap
$416M
Insider Score
Health Score
Listed since
Feb 6, 2026
Website
Insider Score
/ 100
AGMB Insider Score

AgomAb Therapeutics NV has a live Insider Score.

Scored on 10 qualifying trades from 3 insiders in the last 90 days.

Unlock the score

Corporate Lobbying

Government lobbying spending instances

Loading filings…

Source: U.S. Senate LDA

Corporate Lobbying

AGMB Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New AGMB patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to AGMB from public contracts

Source: USAspending.gov

Recently reported changes in AGMB holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Congressional Trades

U.S. House and Senate disclosures referencing AGMB, reported under the STOCK Act.

PoliticianChamberActionAmountDate
No congressional trades recorded for AGMB.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.